MedPath

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

Completed
Conditions
Vertebral Artery Ischemia
Arterial Occlusive Diseases
Ischemic Stroke
Vertebrobasilar Insufficiency
Interventions
Other: Conservative treatment (CT)
Other: Intravenous thrombolysis (IVT)
Other: Endovascular thrombectomy (EVT) ± intravenous thrombolysis (IVT)
Registration Number
NCT05503212
Lead Sponsor
Centre Hospitalier Universitaire Vaudois
Brief Summary

Isolated vertebral artery occlusions (VAO) account for approximately one third of posterior circulation occlusions, but have been given the least attention among posterior circulation strokes. If the two recent ATTENTION and BAOCHE randomized clinical trials have proven the superiority of endovascular thrombectomy (EVT) in basilar artery occlusions, data on the effectiveness and harm of acute revascularization treatment on isolated VAO is scarce. We aim to investigate the impact of acute recanalisation treatments in acute ischemic stroke patients with isolated VAO.

In the absence of RCT, observational data with appropriate statistical methods may give indications on benefits and harms of treating neglected stroke situations like acute vertebral occlusion. Results may also lay the basis for prospective studies, such as randomized clinical trials.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
682
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
AIS and isolated VAOIntravenous thrombolysis (IVT)Patients with acute ischemic stroke (AIS) and concomitant isolated intracranial and/or extracranial vertebral artery occlusion (VAO)
AIS and isolated VAOConservative treatment (CT)Patients with acute ischemic stroke (AIS) and concomitant isolated intracranial and/or extracranial vertebral artery occlusion (VAO)
AIS and isolated VAOEndovascular thrombectomy (EVT) ± intravenous thrombolysis (IVT)Patients with acute ischemic stroke (AIS) and concomitant isolated intracranial and/or extracranial vertebral artery occlusion (VAO)
Primary Outcome Measures
NameTimeMethod
3-month modified Rankin scale90 days

3-month functional outcome, \[range: 0-6, 0= no symptoms, 6=death\]

Secondary Outcome Measures
NameTimeMethod
EVT procedural complicationsDuring EVT procedure or peri-procedural

Any complication attributed to the procedure (vessel perforation, vasospasm, dissection, Subarachnoid haemorrhage (SAH)/Intracerebral haemorrhage (ICH), device detachment/misplacement, embolization to new territory, access-site complications, early reocclusion, other)

Cerebrovascular ischemic recurrences90 days

Any ischemic stroke or transient ischemic attack recurrence \[yes/no\]

Symptomatic intracerebral haemorrhage (sICH)7 days

Any hemorrhagic transformation temporally related to any worsening in neurological condition. \[yes/no\]

24-hour NIHSS24 hours

NIH Stroke Scale/Score (NIHSS). Quantifies stroke severity based on weighted clinical evaluation findings at 24h. \[0-42, 0= no deficit, 42=maximum stroke severity\]

Vessel recanalisation on follow up-imaging48 hours

Vessel recanalisation at follow-up imaging (0= no recanalisation, 1= partial recanalisation 50-99%, 2=full recanalisation, 3= initially not occluded)

Early neurological deterioration (ENDi)24 hours

Early neurological deterioration of ischemic origin (ENDi) is defined as an increase in National Institute of Health Stroke (NIHSS) score ≥ 4 points or death within 24 hours. \[yes/no\]

24h and 3month mortality24h and 90 days

Mortality at 24h and 3 months

Trial Locations

Locations (1)

Centre Hospitalier Universitaire Vaudois

🇨🇭

Lausanne, VD, Switzerland

© Copyright 2025. All Rights Reserved by MedPath